Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > F Douglas Kling > Profile

F Douglas Kling

Affiliations

  • Chief Operating Officer at Newamsterdam Pharma Co N.v. (NAMS), 2025-04-17
  • See Remarks at Matinas Biopharma Holdings Inc. (MTNB), 2017-03-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Newamsterdam Pharma Co N.v.
 NAMS $0.00 910 44,000 2025-04-15 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 99,090 44,910 2025-04-15 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 16,539 44,000 2025-03-26 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 100,000 44,000 2025-03-17 Filing
Newamsterdam Pharma Co N.v.
 NAMS $0.00 9,218 44,000 2025-02-19 Filing